Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
In chemotherapy-treated breast cancer, wild-type p53 preferentially induces senescence over apoptosis, resulting in a persisting cell population constituting residual disease that drives relapse and poor patient survival via the senescence-associated secretory phenotype. Understanding the properties of tumor cells that allow survival after chemotherapy treatment is paramount. Using time-lapse and confocal microscopy to observe interactions of cells in treated tumors, we show here that chemotherapy-induced senescent cells frequently engulf both neighboring senescent or nonsenescent tumor cells at a remarkable frequency. Engulfed cells are processed through the lysosome and broken down, and cells that have engulfed others obtain a survival advantage. Gene expression analysis showed a marked up-regulation of conserved macrophage-like program of engulfment in chemotherapy-induced senescent cell lines and tumors. Our data suggest compelling explanations for how senescent cells persist in dormancy, how they manage the metabolically expensive process of cytokine production that drives relapse in those tumors that respond the worst, and a function for their expanded lysosomal compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although still poorly understood, chemotherapy-resistant senescent cells can engulf neighboring normal and tumor cells by phagocytosis for survival advantage [229].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Real-time PCR was performed on a QuantStudio6 (Applied Biosystems) using Sybr Green (Bio-Rad) and analysis as per Pfaffl (2001), as previously described (Jackson et al., 2012).”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · cited 2×
“…senescent cells process engulfed cells to the lysosome Senescent cells have a vastly expanded lysosomal compartment that is detected by the SA-βGAL assay (Kurz et al., 2000; Lee et al., 2006), which is used widely as a marker for senescence (Dimri et al., 1995; Sharpless and Sherr, 2015).”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 3×
“, 2006), is a well-described feature of many senescent cell types, both in vivo and in vitro, in normal and cancer cells (Jackson et al., 2012; Sharpless and Sherr, 2015), including chemotherapytreated breast cancers (te Poele et al.”
BackgroundInfluentialDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“TP53 mutant cells are more sensitive to DNA damage (Brown and Wouters, 1999; Bunz et al., 1999), but cells that survive can undergo p53-independent senescence in culture (Chang et al.”
BackgroundKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
Research works printed but not linked: 1
- Tonnessen-Murray C., Lozano G., and Jackson J.G. 2016 The p53 Protein: From Cell Regulation to Cancer. In Lozano G., and Levine A.J., editors. The p53 Protein: From Cell Regulation to Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 173– 186.
Cited by
Items 101–127 of 127
The Three Barriers Senescent Tumor Cells Must Overcome to Relapse
Jackson, J. G. (2025) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2502030013 · Cited by 1
Self-citationTyrna, P., Kostro, J. M., Olszanecka, M., Szukało, P., & Młynarczuk-Biały, I. (2025) · Cells · doi:10.3390/cells14191500 · Cited by 1
“This distinguishes entosis from a morphologically similar phenomenon, cell cannibalism [11,12].”
Towards a context-aware framework for cellular senescence
Nath, A., Mehrotra, P., Bhattacharyya, C., & Saini, D. K. (2026) · Biogerontology · doi:10.1007/s10522-026-10440-1 · Cited by 1
Therapy Induced Senescence Promote Expression of Death Receptors in Breast Cancer Cells
Eren, M. K., Pilevneli, H., Ak, C., Karlıtepe, A., & Kaygusuz, N. (2021) · Tıpta Yenilikçi Yaklaşımlar Dergisi · doi:10.29329/jiam.2020.299.1 · Cited by 2
Stress-induced senescence as a forme fruste of chronic kidney disease—A case for failed regeneration
Goligorsky, M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00001-9 · Cited by 1
Enrichment of CD44+/CD24+ cells predicts chemoresistance in luminal breast cancerPreprint
Tang, P., Wu, J., Ma, Q., Liu, W., Wang, M., Yan, Y., Hu, Y., Zhong, L., & Chen, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1326838/v1 · Cited by 1
Bozkurt, E., Kısakol, B., Düßmann, H., Lucantoni, F., Sturrock, A., Azimi, M., Cho, S., McDonough, E., Fay, J., O’Grady, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.15.662825 · Cited by 1
Huang, X., Wang, C., & Wang, N. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01815-0
“For instance, chemotherapy drugs can generate pro-tumorigenic and pro-metastatic effects[1], and promote cancer cell evolution, which contribute to cancer recurrence and resistance to anti-tumor therapy [2].”
BackgroundSenotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
Optimismo ante la nueva OCM y pesimismo por el futuro del tabaco
Guerra, Á. (2000) · Vida rural
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_10
Scott, M. (2022) · Edinburgh University Press eBooks · doi:10.1515/9781474486194-013
Baker, A. G., Ou, H., Hartono, M., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., Sanghera, C., González‐Gualda, E., Macías, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.12.548691
The extracellular matrix in peritoneal metastatic carcinoma
Qiu, Y. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/15/20240464
Mutant p53 induces SH3BGRL expression to promote cell engulfment
Dolma, L., Patterson, M. I., Banyard, A., Hall, C., Bell, S., Breitwieser, W., Sahoo, S., Weightman, J., Gil, M. P., Ashton, G., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02582-x · Cited by 3
“Some other studies support a pro-tumorigenic role of CIC structures [9 – 11], but anti-tumorigenic roles have also been reported [12, 13].”
Aqbi, H. F., Coleman, C., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161722
Aqbi, H. F., Coleman, C., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161707
Aqbi, H. F., Coleman, C., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161713
Shazia, I., Tsui, H. Y. C., Chen, S., Li, X., Mat, W., Khan, M. A., Choy, L. B., Chan, K.-Y. A., Chan, T.-M. D., Ng, C.-P. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26679509
Aqbi, H. F., Coleman, C., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161716
Aqbi, H. F., Coleman, C., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161719
Targeting Cellular Senescence in Prostate Cancer: Molecular Landscape and Therapeutic Avenues
Hossam, H., & Alattaibi, B. (2026) · annals of urologic oncology · doi:10.32948/auo.2026.01.25
Molecular mechanisms of drug-tolerance to EGFR-targeted therapies in lung adenocarcinoma
Léonce, C. (2021) · theses.fr (ABES) · doi:10.70675/0611e924z7044z428cz90dcz9235e0a4b5a2
Cell-autonomous immunity model of aging and disease
Wu, F., Winer, D. A., & Furman, D. (2026) · Trends Open · doi:10.1016/j.treopn.2026.04.012
Zheng, L., Duan, S., Li, Y., Che, H., Liang, Y., Zhang, X., Lin, B., Li, C., Deng, J., Qiu, X., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10575289/v1
Du, L., Zhang, Y., Liang, R., Song, B., Zhou, J., 夏贤武, Liu, C., Wu, K., & Cao, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01847-x
“…regulated necrosis—as well as more recently emerging programs such as disulfidptosis, are not discussed in depth here, because their interplay with cellular senescence in cancer remains less well characterized; we direct interested readers to recent focused literature [8, 66, 71, 72].”
Lin, Y.-Y., Chao, H.-C., Liao, T., Chen, Y.-Q., Lin, Y.-H., Lan, H., Lin, W., Lin, Y.-T., Teng, H.-W., & Hwang, W. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105082
Metadata
- Authors
- Tonnessen-Murray, C. A., Frey, W. D., Rao, S. G., Shahbandi, A., Ungerleider, N. A., Olayiwola, J. O., Murray, L. B., Vinson, B. T., Chrisey, D. B., Lord, C. J., & Jackson, J. G.
- Affiliations
- Tulane University (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Jackson, James G.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2019-09-17
- Volume
- 218
- Issue
- 11
- Pages
- 3827-3844
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC6829672
- OpenAlex
- W2973542731
- Cited by
- 127
- References
- 59
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 23 · 2023: 16 · 2022: 20 · 2021: 18 · 2020: 25 · 2019: 6
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH-14-1-0216)
- National Institutes of Health
- National Institute of General Medical Sciences (1P30GM114732-01, U54 GM104940)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- chemotherapy-induced senescence, senescence-associated secretory phenotype, breast cancer, p53, cell engulfment, lysosomal degradation, tumor cell survival, relapse, cytokine production, lysosomes
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Cell Survival, Doxorubicin, Humans, Tumor Cells, Cultured, Cellular Senescence, Cell Proliferation, Mice, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.